Yarrowbioscience
1 known investors
Yarrow Bioscience develops a first-in-class anti-TSHR antibody to treat thyroid autoimmune diseases, specifically Graves' disease and thyroid eye disease. It operates in the biotech and therapeutics space.
Investors · 1
Frequently asked questions
- What does Yarrowbioscience do?
- Yarrow Bioscience develops a first-in-class anti-TSHR antibody to treat thyroid autoimmune diseases, specifically Graves' disease and thyroid eye disease. It operates in the biotech and therapeutics space.
- Who are Yarrowbioscience's investors?
- Yarrowbioscience's investors include OrbiMed.